Kenvue Inc. (KVUE) Total Return CAGR:-9.89%(TTM)
Over the latest trailing 12-month period, Kenvue Inc. (KVUE)'s total return cagr is -9.89%. The comparable SPY value is +22.76%. Year-to-date total return is +9.22%. Total return includes price appreciation and reinvested dividends.
Over longer horizons, Kenvue Inc.'s Total Return CAGR averages -7.76% over 3 years. Total return includes dividends reinvested. The total return CAGR includes both price appreciation and dividends reinvested. This gives a more complete picture of Kenvue Inc.'s investment performance.
KVUE Total Return CAGR Chart
Kenvue Inc. (KVUE)
KVUE Quarterly Total Return (YoY)
Total Return Index growth vs the same quarter one year earlier, last 9 quarters.
KVUE Total Return CAGR History
| Year | Start Total Return | End Total Return | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2026 | 70.72 | 77.25 | +6.52 | +9.22% | +9.22% |
| 2025 | 84.07 | 70.72 | -13.34 | -15.87% | -15.87% |
| 2024 | 81.56 | 84.07 | +2.51 | +3.08% | +3.08% |
Quarterly Total Return: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q2 2026 | 77 | +8.1% | -8.0% |
| Q1 2026 | 71 | +1.1% | -25.0% |
| Q4 2025 | 71 | +7.6% | -15.9% |
| Q3 2025 | 66 | -21.7% | -27.2% |
| Q2 2025 | 84 | -11.9% | +19.5% |
| Q1 2025 | 95 | +13.4% | +16.1% |
| Q4 2024 | 84 | -6.9% | +3.1% |
| Q3 2024 | 90 | +28.5% | +19.9% |
| Q2 2024 | 70 | -14.4% | -28.4% |
| Q1 2024 | 82 | +0.7% | — |
| Q4 2023 | 82 | +8.3% | — |
| Q3 2023 | 75 | -23.3% | — |
| Q2 2023 | 98 | — | — |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Kenvue Inc.
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- CEO
- Kirk L. Perry